Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis
…, A Musubire, K Taseera, HW Nabeta… - … England Journal of …, 2014 - Mass Medical Soc
Background Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
…, BM Morawski, KH Hullsiek, HW Nabeta… - The Lancet infectious …, 2016 - thelancet.com
Background Cryptococcus is the most common cause of adult meningitis in Africa. We assessed
the safety and microbiological efficacy of adjunctive sertraline, previously shown to have …
the safety and microbiological efficacy of adjunctive sertraline, previously shown to have …
The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis
…, KH Hullsiek, J Rhein, HW Nabeta… - Clinical infectious …, 2014 - academic.oup.com
Introduction. Cryptococcal meningitis is the most common cause of adult meningitis in sub-Saharan
Africa. Raised intracranial pressure (ICP) is common in cryptococcosis. Prior studies …
Africa. Raised intracranial pressure (ICP) is common in cryptococcosis. Prior studies …
Novel antifungal activity of Q-Griffithsin, a broad-spectrum antiviral lectin
HW Nabeta, JC Kouokam, AB Lasnik… - Microbiology …, 2021 - Am Soc Microbiol
There is a rising global incidence of Candida strains with high levels of resistance to fluconazole
and other antifungal drugs, hence the need for novel antifungal treatment strategies. …
and other antifungal drugs, hence the need for novel antifungal treatment strategies. …
Accuracy of noninvasive intraocular pressure or optic nerve sheath diameter measurements for predicting elevated intracranial pressure in cryptococcal meningitis
Background. Cryptococcal meningitis is associated with increased intracranial pressure (ICP).
Therapeutic lumbar puncture (LP) is recommended when the initial ICP is >250 mm H 2 O…
Therapeutic lumbar puncture (LP) is recommended when the initial ICP is >250 mm H 2 O…
Immunity to commensal papillomaviruses protects against skin cancer
…, ME Awad, T Li, T Hasegawa, DT Ha, HW Nabeta… - Nature, 2019 - nature.com
Immunosuppression increases the risk of cancers that are associated with viral infection 1 .
In particular, the risk of squamous cell carcinoma of the skin—which has been associated …
In particular, the risk of squamous cell carcinoma of the skin—which has been associated …
Serum vitamin D status in children with protein-energy malnutrition admitted to a national referral hospital in Uganda
HW Nabeta, J Kasolo, RK Kiggundu, AN Kiragga… - BMC research …, 2015 - Springer
Background Vitamin D deficiency is a world-wide epidemic with recent estimates indicating
that greater than 50 % of the global population is at risk. In Uganda, 80 % of healthy …
that greater than 50 % of the global population is at risk. In Uganda, 80 % of healthy …
Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis
HW Nabeta, AB Lasnik, JL Fuqua, L Wang… - Frontiers in Cellular …, 2022 - frontiersin.org
Resistance to antifungal agents in vulvovaginal candidiasis has resulted in increasing morbidity
among women globally. It is therefore crucial that new antimycotic agents are developed …
among women globally. It is therefore crucial that new antimycotic agents are developed …
Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis
…, J Rhein, BM Morawski, R Kiggundu, HW Nabeta… - …, 2016 - academic.oup.com
Quantitative cerebrospinal fluid (CSF) cultures provide a measure of disease severity in
cryptococcal meningitis. The fungal clearance rate by quantitative cultures has become a …
cryptococcal meningitis. The fungal clearance rate by quantitative cultures has become a …
A Phase 1a/1b Clinical Trial Design to Assess Safety, Acceptability, Pharmacokinetics and Tolerability of Intranasal Q-Griffithsin for COVID-19 Prophylaxis
HW Nabeta, M Zahin, JL Fuqua… - The University of …, 2022 - ir.library.louisville.edu
Background: The COVID-19 pandemic remains an ongoing threat to global public health. Q-Griffithsin
(Q-GRFT) is a lectin that has demonstrated potent broad-spectrum inhibitory …
(Q-GRFT) is a lectin that has demonstrated potent broad-spectrum inhibitory …